Pledge Agreements in the Pharmaceuticals Industry
28 Contracts & Agreements
- Astex Pharmaceuticals, Inc (2 contracts)
- Bohai Pharmaceuticals Group, Inc. (1)
- Canbiola, Inc. (1)
- Clever Leaves Holdings Inc. (8)
- Furiex Pharmaceuticals, Inc. (1)
- Lotus Pharmaceuticals, Inc. (1)
- NEKTAR THERAPEUTICS (4)
- Notis Global, Inc. (1)
- Pacira Pharmaceuticals, Inc. (1)
- Phoenix Life Sciences International Limited. (1)
- Processa Pharmaceuticals, Inc. (1)
- ROCK CREEK PHARMACEUTICALS, INC. (1)
- SALIX PHARMACEUTICALS LTD (1)
- TILT Holdings Inc. (3)
- Tribute Pharmaceuticals Canada Inc. (1)
- Membership Interest Pledge Agreement dated as of August 23, 2024 between Can B Corp. and Pasquale Ferro (Canbiola, Inc., Filed With SEC on November 19, 2024)
- Equity Pledge Agreement, dated January 28, 2024, by Jimmy Jang, L.P. in favor of Shenzhen Smoore Technology Limited (TILT Holdings Inc., Filed With SEC on January 31, 2024)
- Pledge Agreement dated May 15, 2023 by and among TILT Holdings Inc., Jimmy Jang Holdings Inc., Jimmy Jang L.P., Jupiter Research, LLC, Baker Technologies, Inc., Sea Hunter... (TILT Holdings Inc., Filed With SEC on May 19, 2023)
- Amended and Restated Pledge Agreement February 15, 2023 by and among TILT Holdings Inc., Jimmy Jang Holdings Inc., Jimmy Jang L.P., Jupiter Research, LLC, Baker Technologies,... (TILT Holdings Inc., Filed With SEC on February 16, 2023)
- Pledge Agreement, dated as of July 19, 2021, made by Clever Leaves US, Inc. in favor of Catalina LP (Clever Leaves Holdings Inc., Filed With SEC on July 19, 2021)
- Pledge Agreement, dated as of July 19, 2021, made by 1255096 B.C. Ltd. in favor of Catalina LP (Clever Leaves Holdings Inc., Filed With SEC on July 19, 2021)
- Pledge Agreement, dated as of July 19, 2021, made by Clever Leaves International Inc. in favor of Catalina LP (Clever Leaves Holdings Inc., Filed With SEC on July 19, 2021)
- Pledge Agreement, dated as of July 19, 2021, made by Clever Leaves Holdings, Inc in favor of Catalina LP (Clever Leaves Holdings Inc., Filed With SEC on July 19, 2021)
- Pledge Agreement, dated as of December 18, 2020, made by Clever Leaves US, Inc. in favor of GLAS Americas LLC, as Collateral Agent (Clever Leaves Holdings Inc., Filed With SEC on December 28, 2020)
- Pledge Agreement, dated as of December 18, 2020, made by 1255096 B.C. LTD. in favor of GLAS Americas LLC, as Collateral Agent (Clever Leaves Holdings Inc., Filed With SEC on December 28, 2020)
- Pledge Agreement, dated as of December 18, 2020, made by Clever Leaves Holdings Inc. in favor of GLAS Americas LLC, as Collateral Agent (Clever Leaves Holdings Inc., Filed With SEC on December 28, 2020)
- Second Amended and Restated Pledge Agreement, dated as of December 18, 2020, made by Clever Leaves International Inc. in favor of GLAS Americas LLC, as Collateral Agent (Clever Leaves Holdings Inc., Filed With SEC on December 28, 2020)
- Pledge Agreement dated May 25, 2018, by and between Processa Pharmaceuticals, Inc. and PoC Capital, LLC (Processa Pharmaceuticals, Inc., Filed With SEC on October 9, 2018)
- Membership Interest Pledge Agreement (Notis Global, Inc., Filed With SEC on October 21, 2016)
- [Signature Page to Membership Interest Pledge Agreement] (Phoenix Life Sciences International Limited., Filed With SEC on July 16, 2014)
- CANADIAN COLLATERAL PLEDGE AGREEMENT (Tribute Pharmaceuticals Canada Inc., Filed With SEC on March 22, 2013)
- PLEDGE AGREEMENT (Furiex Pharmaceuticals, Inc., Filed With SEC on November 10, 2011)
- PLEDGE AGREEMENT (Pacira Pharmaceuticals, Inc., Filed With SEC on November 1, 2010)
- SECURITIESESCROW AND PLEDGE AGREEMENT (Bohai Pharmaceuticals Group, Inc., Filed With SEC on January 11, 2010)
- EXH. 10.5 PLEDGE AGREEMENT (Lotus Pharmaceuticals, Inc., Filed With SEC on February 15, 2007)
- PLEDGE AGREEMENT (ROCK CREEK PHARMACEUTICALS, INC., Filed With SEC on March 7, 2006)
- PLEDGE AGREEMENT (NEKTAR THERAPEUTICS, Filed With SEC on November 3, 2003)
- PLEDGE AGREEMENT (NEKTAR THERAPEUTICS, Filed With SEC on October 20, 2003)
- PLEDGE AGREEMENT (NEKTAR THERAPEUTICS, Filed With SEC on October 10, 2003)
- PLEDGE AGREEMENT (NEKTAR THERAPEUTICS, Filed With SEC on July 2, 2003)
- AMENDED AND RESTATED PLEDGE AGREEMENT (Astex Pharmaceuticals, Inc, Filed With SEC on June 25, 2003)
- PLEDGE AGREEMENT (Astex Pharmaceuticals, Inc, Filed With SEC on February 27, 2003)
- NEGATIVE PLEDGE AGREEMENT (SALIX PHARMACEUTICALS LTD, Filed With SEC on November 14, 2002)
